Pediatrix Medical Group (NYSE:MD) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $24.46 and traded as high as $26.35. Pediatrix Medical Group shares last traded at $26.2540, with a volume of 729,994 shares.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. UBS Group raised their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Jefferies Financial Group downgraded shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and boosted their target price for the stock from $27.00 to $28.00 in a research report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $25.00 price target on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, September 9th. Finally, Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 13th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus target price of $26.60.

Pediatrix Medical Group Price Performance

The stock has a 50 day moving average of $26.36 and a two-hundred day moving average of $24.47. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market capitalization of $2.16 billion, a P/E ratio of 12.74 and a beta of 0.61.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%. The firm had revenue of $487.78 million during the quarter, compared to analysts’ expectations of $478.49 million. During the same quarter in the prior year, the business earned $0.53 earnings per share. The company’s revenue was up 4.1% on a year-over-year basis. Sell-side analysts predict that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Farther Finance Advisors LLC increased its stake in shares of Pediatrix Medical Group by 258.1% in the third quarter. Farther Finance Advisors LLC now owns 4,225 shares of the company’s stock worth $109,000 after purchasing an additional 3,045 shares during the period. Tidal Investments LLC boosted its stake in Pediatrix Medical Group by 253.9% during the 2nd quarter. Tidal Investments LLC now owns 616,048 shares of the company’s stock valued at $15,604,000 after purchasing an additional 441,959 shares during the period. WINTON GROUP Ltd boosted its stake in Pediatrix Medical Group by 8.9% during the 2nd quarter. WINTON GROUP Ltd now owns 57,413 shares of the company’s stock valued at $1,454,000 after purchasing an additional 4,710 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in Pediatrix Medical Group in the 2nd quarter valued at approximately $53,000. Finally, Nykredit A S acquired a new stake in Pediatrix Medical Group in the 2nd quarter valued at approximately $35,000. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc provides physician-led health care services to hospitals, health systems and patients across the United States. The company focuses on specialized care for women, infants and children, supporting patients in hospital-based and affiliated clinical settings.

Its services include neonatal and perinatal care, maternal-fetal medicine, pediatric cardiology and other pediatric subspecialties. Pediatrix physicians commonly practice in neonatal intensive care units, delivery rooms, pediatric emergency departments and other hospital departments, working with care teams to manage complex medical needs.

The company was founded in 1979 and operated for many years under the name MEDNAX, Inc It adopted the Pediatrix Medical Group name in 2023 as part of a broader effort to emphasize its pediatric, neonatal and maternal-fetal health care businesses.